Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt

At the beginning of 2019, Takeda Pharmaceutical announced plans to sell about $10 billion worth of assets to offset some of the debt the company garnered in its $62 billion acquisition of Shire. In May, the company sold off assets worth $5.7 billion and now, the company is looking to sell more.